货号:A103870
同义名:
Ivabradine (hydrochloride); S 16257
vabradine HCl 是一种 HCN (超极化激活的环核苷酸门控) 通道阻滞剂,能够抑制心脏起搏器电流 (If)。Ivabradine HCl 具有抗惊厥、抗缺血和抗心绞痛活性,可用于心率控制相关的研究和治疗。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Adrenergic Receptor ↓ ↑ | α-adrenergic receptor ↓ ↑ | β-adrenergic receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivabradine HCl | ✔ | 98% | |||||||||||||||||
| Maprotiline HCl | ✔ | 98% | |||||||||||||||||
| Cisatracurium besylate | ✔ | 96% | |||||||||||||||||
| Yohimbine HCI | ✔ | 99+% | |||||||||||||||||
| BMY 7378 |
++
α2C-adrenoceptor, pKi: 6.54 α1D-adrenoceptor, pKi: 5.1 |
+
β1-adrenoceptor, pIC50: 5.1 |
97% | ||||||||||||||||
| Asenapine maleate |
++++
α2B-adrenergic receptor, pKi: 8.9 α2A-adrenergic receptor, pKi: 8.9 |
97% | |||||||||||||||||
| Piribedil |
++
adrenoceptor α2C, pKi: 7.2 adrenoceptor α2A, pKi: 7.1 |
98% | |||||||||||||||||
| Prazosin HCl | ✔ | 95% | |||||||||||||||||
| Silodosin | ✔ | 98% | |||||||||||||||||
| Phenoxybenzamine HCl | ✔ | 98% | |||||||||||||||||
| Labetalol HCl | ✔ | 98+% | |||||||||||||||||
| Naftopidil |
+++
α1A-adrenergic receptor, Ki: 3.7 nM α1D-adrenergic receptor, Ki: 20 nM |
98% | |||||||||||||||||
| Naftopidil 2HCl |
+
α1-adrenergic receptor, IC50: 0.2 μM |
99% | |||||||||||||||||
| Alfuzosin HCl | ✔ | 98% | |||||||||||||||||
| Terazosin HCl | ✔ | 99% | |||||||||||||||||
| Atipamezole | ✔ | 95% | |||||||||||||||||
| Phentolamine methanesulfonate salt | ✔ | 99% | |||||||||||||||||
| Carvedilol | ✔ | 99% | |||||||||||||||||
| Doxazosin mesylate | ✔ | 99% | |||||||||||||||||
| Tolazoline HCl | ✔ | 98% | |||||||||||||||||
| Esmolol HCl | ✔ | 95% | |||||||||||||||||
| Propranolol HCl |
++
β-adrenergic receptor, IC50: 12 nM |
99% | |||||||||||||||||
| Zenidolol HCl |
++++
β1-adrenergic receptor, Ki: 611nM β2-adrenergic receptor, Ki: 0.7nM |
98% | |||||||||||||||||
| Acebutolol HCl | ✔ | 97+% | |||||||||||||||||
| Carteolol HCl | ✔ | 98+% | |||||||||||||||||
| Betaxolol | ✔ | 99% | |||||||||||||||||
| Betaxolol HCl |
+
β1-adrenergic receptor, IC50: 6 μM |
97% | |||||||||||||||||
| Bisoprolol | ✔ | 97% | |||||||||||||||||
| Sotalol HCl | ✔ | 95+% | |||||||||||||||||
| Nebivolol HCl |
+++
β1-adrenoceptor, IC50: 0.8 nM |
99% | |||||||||||||||||
| Metoprolol | ✔ | 98+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Ivabradine Hydrochloride is a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide-gated channels, inducing heart rate (HR) reduction[3]. Ivabradine at 10 mg/kg/day reduced the maximal HR increase in response to the β-agonist isoproterenol, without modifying the response of contractile parameters [4]. Ivabradine induced a time-dependent inhibition of hHCN4 with an IC50 of 0.5 μM. Ivabradine 3 μM decreased the frequency of action potentials in SAN (sino-atrial nodes) from guinea-pig, rabbit and pig by 33%, 21% and 15% at 40 min, respectively[5]. |
| Concentration | Treated Time | Description | References | |
| MCF-10A | 5 µM | 2 weeks | Clin Transl Med. 2021 Nov;11(11):e578. | |
| MDA-MB-453 | 5 µM | 2 weeks | Suppressed cell proliferation | Clin Transl Med. 2021 Nov;11(11):e578. |
| MDA-MB-231 | 5 µM | 2 weeks | Suppressed cell proliferation | Clin Transl Med. 2021 Nov;11(11):e578. |
| SAN myocytes | 1 µM | To evaluate the effect of Ivabradine on the spontaneous beating rate of SAN cells, results showed Ivabradine reduced the beating rate in control cells but had no effect on mutant cells. | Nat Commun. 2014 Aug 21;5:4664. | |
| HEK293 cells | 30 μM | Assess the current properties of HCN4 channels under AP clamp | Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):e2104668118. | |
| Murine sinoatrial node myocytes | 30 μM | 120 seconds | Evaluate the blocking effect of ivabradine on If current | Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):e2104668118. |
| SAN pacemaker cells | 3 or 10 µM | To evaluate the inhibitory effect of Ivabradine on If current in SAN cells, showing similar inhibition in both control and mutant groups. | Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12189-94. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Type 1 and Type 2 diabetes models | Intraperitoneal injection | 2.5 mg/kg, 5 mg/kg, 10 mg/kg | Single or multiple injections | Ivabradine significantly reversed mechanical hypersensitivity in diabetic mice in a dose-dependent manner. Multiple injections completely restored pain thresholds to pre-diabetic levels. | Sci Transl Med. 2017 Sep 27;9(409):eaam6072 |
| Mice | Diabetic mouse model | Oral | 20 mg/kg/day | Once daily for 4 weeks | To investigate the effect of selective heart rate reduction on cardiovascular function and ventricular-arterial coupling in a diabetic mouse model. Results showed that Ivabradine improved vascular stiffness and left ventricular systolic and diastolic function. | Eur Heart J. 2013 Sep;34(36):2839-49 |
| Mice | Swim training model | Oral | 7.5 mg | Single dose | To assess the effect of Ivabradine on heart rate | Circ Res. 2017 Oct 13;121(9):1058-1068 |
| Mice | Ncx1−/− mice | 30 µM | To investigate the effect of Ivabradine on the automaticity of SAN cells in Ncx1?/? mice, results showed that under basal conditions, Ivabradine similarly reduced SAN cell automaticity in both Ncx1?/? and control mice; however, after isoproterenol stimulation, SAN cells from Ncx1?/? mice were significantly more sensitive to Ivabradine | Circ Res. 2013 Jan 18;112(2):309-17 | ||
| Mice | HHCN4-AYA transgenic mice | Intraperitoneal injection | 6 mg/kg | Single dose | To evaluate the effect of Ivabradine on heart rate, results showed Ivabradine reduced heart rate in control mice but had no effect on mutant mice. | Nat Commun. 2014 Aug 21;5:4664. |
| Mice | Cardiac-specific TRPM7 knockout mice | 3 mg/kg and 6 mg/kg | KOαMHC-Cre mice were less sensitive to the negative chronotropic effects of ivabradine compared to wild-type mice | Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E3037-46 | ||
| Mice | Atrial-specific NCX knockout mice | Perfusion | 3 μM | Suppressed NCX KO SAN automaticity, reducing burst firing activity | Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9769-74 | |
| Nude mice | MDA-MB-231 xenograft model | Subcutaneous injection | 15 mg/kg | Once daily for 4 weeks | Significantly reduced tumor volume | Clin Transl Med. 2021 Nov;11(11):e578. |
| Mice | Conditional hHCN4–573X transgenic mice | Intraperitoneal injection | 3 or 6 mg/kg | Single dose, observed for 3 hours | To assess the effect of Ivabradine on heart rate, showing significant reduction in controls but no effect in mutants. | Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12189-94. |
| Mice | Oxaliplatin-induced cold hypersensitivity model | Intraperitoneal injection | 3 mg/kg | Single injection | To evaluate the effect of ivabradine on oxaliplatin-induced cold hypersensitivity, it was found that ivabradine significantly alleviated cold hypersensitivity | EMBO Mol Med. 2011 May;3(5):266-78 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.98mL 0.40mL 0.20mL |
9.90mL 1.98mL 0.99mL |
19.80mL 3.96mL 1.98mL |
|
| CAS号 | 148849-67-6 |
| 分子式 | C27H37ClN2O5 |
| 分子量 | 505.05 |
| SMILES Code | Cl[H].COC1=CC2=C(CC(=O)N(CCCN(C)C[C@H]3CC4=CC(OC)=C(OC)C=C34)CC2)C=C1OC |
| MDL No. | MFCD00929899 |
| 别名 | Ivabradine (hydrochloride); S 16257; Ivabradine hydrochloride |
| 运输 | 蓝冰 |
| InChI Key | HLUKNZUABFFNQS-ZMBIFBSDSA-N |
| Pubchem ID | 3045381 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
| 溶解方案 |
DMSO: 25 mg/mL(49.5 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(99 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1